tradethepoolpool ads

Gilead Sciences, Inc. (NASDAQ:GILD) is the Stock of the Week

Gilead Sciences, Inc. (NASDAQ:GILD) has been selected as the Stock of the Week by Stock Traders Daily this week.  After recent eye popping increases in the stock price and corresponding increases in earnings the stock has become quite volatile and that makes it an exceptional trading vehicle for proactive traders who pay attention to stock price fluctuations.  The objective of our Stock of the Week strategy is to take advantage of those fluctuations.

Although the Stock of the Week strategy is focused on trading, the fundamental condition of the company must also be evaluated.  Our fundamental observations suggest that Gilead not only has had impressive recent earnings growth, but earnings are expected to at least sustain current levels if not grow even more.  The earnings graph below shows how significant the growth has been.

For longer-term investors, they must also consider additional risk factors that have surfaced, and arguably these are the reasons the stock came under more severe pressure recently, but that is what proactive trading strategies look for.  Proactive strategies that take advantage of volatility look for stocks that move, and Gilead has been such a stock.

Initially, as expectations ran high (still running high) for the hepatitis C drug, the stock surged.  Investors expected huge results, and then they got them, and as expected some investors decided to sell the news.  Then the question about pricing and complaints by government officials hastened the retracement in the stock's price, but that also has seemed to be short lived thus far.

We're not passing judgment on Gilead's product, pricing structure, or the probability of government regulations impeding upon their business model, but instead, this week, we are embracing Gilead as the Stock of the Week because it has been volatile and we expect it to continue to be volatile.

The Stock of the Week strategy was developed in December, 2007, before the Credit Crisis hit, it is proactive and risk controlled, and it is designed to work no matter where the market goes.  In this immediate example, although Gilead is our Stock of the Week, it has also been called as a short.

According to our combined analysis and our real time trading report for GILD, we first expected the market to increase to test a resistance level during this week's trading session, and then we expected it to begin to turn down.  In our stock-correlation filters Gilead was featured prominently as a stock that was poised to test a resistance level of its own and then also turn down too (correlation).

This week is not over, but Gilead has triggered and the position is in play.  An integral rule of this Stock of the Week strategy is also to end every week in cash, so regardless of what happens, come Friday at the close of business this strategy will end in cash so we can again approached the market objectively in our evaluation for the forthcoming week.  An added bonus is that by ending in cash we also do not carry market pressures with us over the weekend and we're able to be more present with family and friends.

Understandably, that does not seem like a very important quality right now, but when the market declines and pressures mount that is extremely valuable and it is one of the reasons the Stock of the Week Strategy is up so significantly versus the market since December, 2007, when it began.

Triggers may have already come
Support and Resistance Plot Chart for

Blue = Current Price
Red= Resistance
Green = Support

Real Time Updates for Repeat Institutional Readers:

Factset: Request User/Pass

Bloomberg, Reuters, Refinitiv, Zacks, or IB users: Access Here.

Our Market Crash Leading Indicator is Evitar Corte.
  • Evitar Corte warned of market crash risk four times since 2000.

  • It identified the Internet Debacle before it happened.

  • It identified the Credit Crisis before it happened.

  • It identified the Corona Crash too.

  • See what Evitar Corte is Saying Now.

Get Notified When our Ratings Change: Take a Trial